Adeolu Oluwasanmi
Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy
Oluwasanmi, Adeolu; Al-Shakarchi, Wejdan; Manzur, Ayesha; Aldebasi, Mohammed H.; Elsini, Rayan S.; Albusair, Malek K.; Haxton, Katherine J.; Curtis, Anthony D.M.; Hoskins, Clare
Authors
Wejdan Al-Shakarchi
Ayesha Manzur
Mohammed H. Aldebasi
Rayan S. Elsini
Malek K. Albusair
Katherine Haxton k.j.haxton@keele.ac.uk
Anthony Curtis a.d.m.curtis@keele.ac.uk
Clare Hoskins
Abstract
Hybrid nanoparticles (HNPs) have shown huge potential as drug delivery vehicles for pancreatic cancer. Currently, the first line treatment, gemcitabine, is only effective in 23.8% of patients. To improve this, a thermally activated system was developed by introducing a linker between HNPs and gemcitabine. Whereby, heat generation resulting from laser irradiation of the HNPs promoted linker breakdown resulting in prodrug liberation. In vitro evaluation in pancreatic adenocarcinoma cells, showed the prodrug was 4.3 times less cytotoxic than gemcitabine, but exhibited 11-fold improvement in cellular uptake. Heat activation of the formulation led to a 56% rise in cytotoxicity causing it to outperform gemcitabine by 26%. In vivo the formulation outperformed free gemcitabine with a 62% reduction in tumor weight in pancreatic xenografts. This HNP formulation is the first of its kind and has displayed superior anti-cancer activity as compared to the current first line drug gemcitabine after heat mediated controlled release.
Citation
Oluwasanmi, A., Al-Shakarchi, W., Manzur, A., Aldebasi, M. H., Elsini, R. S., Albusair, M. K., …Hoskins, C. (2017). Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. Journal of Controlled Release, 355-364. https://doi.org/10.1016/j.jconrel.2017.09.027
Acceptance Date | Sep 18, 2017 |
---|---|
Publication Date | Sep 22, 2017 |
Journal | Journal of Controlled Release |
Print ISSN | 0168-3659 |
Publisher | Elsevier |
Pages | 355-364 |
DOI | https://doi.org/10.1016/j.jconrel.2017.09.027 |
Keywords | Pancreatic cancer; Gemcitabine; Hybrid nanoparticle; Thermo-responsive drug delivery; Diels Alder |
Publisher URL | https://doi.org/10.1016/j.jconrel.2017.09.027 |
Files
Clare Hoskins MANUSCRIPT.docx
(7.5 Mb)
Document
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
10 years of curriculum change viewed through the lens of student workload
(2023)
Journal Article
Decolonising the Science Curriculum
(2022)
Report
From Nantwich to Oxygen: Public Engagement in Chemistry at a Local History Museum
(2021)
Journal Article
Developing the Scientific Reporting Skills of Chemistry Students
(2020)
Book Chapter
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search